Atomoxetine 10mg Tablet

Atomoxetine 10mg Tablet contains atomoxetine, a selective norepinephrine reuptake inhibitor used as part of the treatment of attention-deficit/hyperactivity disorder (ADHD). Atomoxetine is a non-stimulant ADHD medicine and is prescribed for eligible children, adolescents and adults according to local product labeling. Strattera® is the established reference brand for atomoxetine; generic products may differ in dosage form, inactive ingredients, appearance and manufacturer.

Product Information

Generic Name

Atomoxetine

Active Ingredient

Atomoxetine hydrochloride equivalent to atomoxetine 10mg

Strength

10mg

Drug Class

Selective Norepinephrine Reuptake Inhibitor (SNRI)

Therapeutic Class

Non-Stimulant ADHD Medication

Dosage Form

Tablet

Route

Oral

Reference Brand

Strattera® 10mg

Primary Indication

Attention-Deficit/Hyperactivity Disorder (ADHD)

Prescription Status

Prescription medicine; status varies by country

Manufacturer

Varies by generic product

Pack Size

Varies by manufacturer and market

Atomoxetine 10mg and Strattera®

Strattera® is a reference brand of atomoxetine. Generic atomoxetine products contain the same active pharmaceutical ingredient, but the exact dosage form, excipients, capsule or tablet appearance, packaging and manufacturer can differ.

Strattera 10mg is documented as a hard capsule in several markets, including the UK and UAE. Some generic atomoxetine products are available in other oral presentations, including 10mg tablet formulations in certain European markets.

Why Is the 10mg Strength Used?

Atomoxetine is available in multiple strengths so that treatment can be individualized according to age, body weight, clinical response, tolerability, liver function and other medicines.

The 10mg strength may form part of a clinician-directed treatment regimen, particularly where a lower strength is needed during treatment adjustment or for certain patient groups. The appropriate dose should be determined from the local prescribing information and the patient's clinical circumstances.

How Should Atomoxetine 10mg Be Taken?

Take Atomoxetine exactly as prescribed by your doctor or pharmacist.

The appropriate dosing schedule depends on factors such as age, body weight, response to treatment, liver function and other medicines. Atomoxetine may be prescribed once or twice daily depending on the treatment plan.

Do not change the dose, open a capsule presentation, switch formulations or discontinue treatment without professional advice. UK patient information specifically advises swallowing atomoxetine capsules whole rather than opening them; this instruction applies to capsule formulations and should not be assumed to describe every tablet formulation.

Atomoxetine Is Not a Traditional Stimulant

Atomoxetine is classified as a non-stimulant ADHD medicine rather than a traditional CNS stimulant. Current UK patient information specifically describes atomoxetine as not being a stimulant.

It should nevertheless be used only under appropriate medical supervision because it has important cardiovascular, psychiatric and drug-interaction considerations.

Availability & Ordering

Atomoxetine 10mg products are marketed under different manufacturers and brand names across international markets. Current examples include generic atomoxetine 10mg products in the UK, Australia and Germany, while Strattera 10mg remains identifiable as the reference brand in markets where it is registered or marketed.

Prescription status, product registration, manufacturer, packaging and availability vary by country. Online supply of prescription atomoxetine should follow the pharmaceutical and prescription requirements of the destination market.

How it works

Atomoxetine selectively inhibits the reuptake of norepinephrine, increasing its availability in relevant areas of the brain. This mechanism can improve attention and help reduce symptoms associated with ADHD. Unlike traditional stimulant ADHD medicines, atomoxetine is classified as a non-stimulant treatment.

Atomoxetine is used to treat attention-deficit/hyperactivity disorder (ADHD). Current U.S. labeling indicates atomoxetine for ADHD in adults and pediatric patients aged 6 years and older, while current UK product information likewise describes use in children over 6 years, young people and adults as part of a broader ADHD treatment program.

Atomoxetine may be prescribed as part of a comprehensive ADHD treatment plan that can include behavioral, psychological, educational or other non-drug interventions.

Atomoxetine requires medical supervision because it can affect cardiovascular, psychiatric and other systems.

Blood pressure and heart rate should be assessed before and during treatment. Atomoxetine can increase blood pressure and heart rate and may require additional caution in patients with cardiovascular or cerebrovascular disease.

Rare but clinically significant liver injury has been reported. Seek medical advice promptly if symptoms such as unexplained jaundice, dark urine, upper abdominal discomfort or unusual tiredness occur.

The U.S. prescribing information carries a boxed warning concerning increased suicidal ideation in pediatric patients aged 6 years and older, particularly during the early stages of treatment or following dosage changes. Children and adolescents taking atomoxetine should be monitored closely for concerning changes in mood or behavior.

Important Precautions and Interactions

Atomoxetine should not be used with monoamine oxidase inhibitors (MAOIs) or within the specified washout period following MAOI treatment. Other important contraindications and precautions include narrow-angle glaucoma, pheochromocytoma and severe cardiovascular conditions in which increases in blood pressure or heart rate could be clinically significant.

Tell your healthcare professional about all medicines and supplements you take. Important interaction considerations can include medicines affecting CYP2D6, antidepressants, medicines that affect blood pressure or heart rhythm, and other drugs that may increase the risk of serotonin syndrome or seizures.